Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Projects & Grants
Research Output
Press/Media
Search by expertise, name or affiliation
KETAMINE FOR TREATMENT RESISTANT LATE-LIFE DEPRESSION
Mathew, Sanjay
(PI)
Icahn School of Medicine at Mount Sinai
Friedman Brain Institute
Psychiatry
Overview
Fingerprint
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Veterans
100%
Ketamine
99%
Treatment-Resistant Depressive Disorder
97%
Depression
47%
Midazolam
40%
Elderly
32%
Antidepressive Agents
32%
N-Methyl-D-Aspartate Receptors
24%
Suicide
22%
Anesthetics
21%
National Institute of Mental Health (U.S.)
16%
Cell Plasticity
16%
Monoamine Oxidase Inhibitors
15%
Electroconvulsive Therapy
14%
Population Dynamics
14%
Benzodiazepines
12%
Random Allocation
11%
Mood Disorders
11%
Electroencephalography
10%
Therapeutics
9%
Population
9%
Data Analysis
9%
Medicine
8%
Research Personnel
8%
Randomized Controlled Trials
8%
Biomarkers
7%
Inflammation
7%